This week in the pharmaceutical industry, there have been several important developments that may impact patients, healthcare providers, and drug

A recent study led by researchers at Yoon et al. suggests that adding a natural compound called sodium caprate (C10)

A biotechnology company called Cellular Intelligence is using artificial intelligence (AI) to help develop a new type of therapy for

Dr. Richard Pazdur, a highly respected leader with 26 years of experience at the U.S. Food and Drug Administration (FDA),

The U.S. Supreme Court has temporarily blocked a federal appeals court ruling in Louisiana that would have stopped doctors from

Eisai, the company that makes the Alzheimer’s drug Leqembi, expects its sales to nearly double next year, reaching about $900

As we move through the first half of 2026, several important updates have been made to medical treatments in the

Biologic drugs, which are more complex than traditional medications, now make up over half of all new drugs in development.